http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105125711-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e16863daa8a575940ff42ccfaf837784 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
filingDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6da5e549f89d11b3637f468669827485 |
publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105125711-A |
titleOfInvention | Pharmaceutical composition for treating diabetic encephalopathy |
abstract | The invention discloses a pharmaceutical composition for treating diabetic encephalopathy and a preparation method thereof. The pharmaceutical composition is prepared by cylindrin, ligularia achyrotricha, lancea tibetica, Curcurbitacin IIa, bamboo reed terpene and oroxylum indicum glycoside A according to proportion. The pharmaceutical composition can be prepared into various forms according to a conventional preparation process and is evident in curative effect on the diabetic encephalopathy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105535067-A |
priorityDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.